|
Volumn 2, Issue 4, 2003, Pages 378-383
|
Linezolid and quinupristin/dalfopristin: novel antibiotics for gram-positive infections of the skin.
a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETAMIDE DERIVATIVE;
ANTIINFECTIVE AGENT;
DALFOPRISTIN PLUS QUINUPRISTIN;
LINEZOLID;
OXAZOLIDINONE DERIVATIVE;
QUINUPRISTIN-DALFOPRISTIN;
VIRGINIAMYCIN;
BACTERIAL INFECTION;
BACTERIAL SKIN DISEASE;
BIOAVAILABILITY;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
DRUG COMBINATION;
HALF LIFE TIME;
HUMAN;
MICROBIOLOGICAL EXAMINATION;
RANDOMIZED CONTROLLED TRIAL;
REVIEW;
ACETAMIDES;
ANTI-BACTERIAL AGENTS;
BIOLOGICAL AVAILABILITY;
DRUG THERAPY, COMBINATION;
GRAM-POSITIVE BACTERIAL INFECTIONS;
HALF-LIFE;
HUMANS;
MICROBIAL SENSITIVITY TESTS;
OXAZOLIDINONES;
RANDOMIZED CONTROLLED TRIALS;
SKIN DISEASES, BACTERIAL;
VIRGINIAMYCIN;
|
EID: 0041568193
PISSN: 15459616
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
Times cited : (13)
|
References (31)
|